Shapuaisi's announcement on amending the "Articles of Association"
Securities code: 603168 Securities abbreviation: Shapuaisi Announcement number: Lin 2025-062 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Announcement on Change of Registered Capital and Amendment of Articles of Association
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 11th meeting of the 6th Board of Directors on October 30, 2025, and reviewed and approved the "Proposal on Amending the Articles of Association". The relevant matters are now announced as follows:
In view of the resignation of some of the first incentive recipients granted in the company's 2023 stock options and restricted stock incentive plan and the failure to meet the company-level performance assessment in 2024, in accordance with the "Company Law of the People's Republic of China", "Equity Incentive Management Measures for Listed Companies" and the company's "2023 Stock Option and Restricted Stock Incentive Plan (Draft)", etc. According to relevant regulations, the company plans to repurchase and cancel 1,798,500 restricted shares that have been granted to relevant incentive targets but have not yet been released from sale restrictions. The total number of company shares will be changed from 375,925,005 shares to 374,126,505 shares, and the company's registered capital will be changed from 375,925,005 yuan to 374,126,505 yuan.
Regarding the above matters, the company plans to amend some of the articles of the "Articles of Association of Zhejiang Shapuaisi Pharmaceutical Co., Ltd." (hereinafter referred to as the "Articles of Association") as follows:
Before revision After revision
Article 6 The registered capital of the company is RMB. Article 6 The registered capital of the company is RMB 375,925,005. (Based on China Securities Depository and Clearing Co., Ltd. 374,126,505 yuan. (Based on the data of Shanghai Branch of China Securities Depository and Clearing Co., Ltd.)
Article 21 The number of shares issued by the company is 375,925,005 shares, all of which are ordinary shares, and 374,126,505 shares, all of which are ordinary shares, are expressed in RMB. (The face value is expressed in the currency of China Securities Depository and Clearing Co., Ltd. (Subject to the data of Shanghai Branch of China Securities Depository and Clearing Co., Ltd.). The data of Shanghai Branch of China Securities Depository and Clearing Co., Ltd. shall prevail). There are no other classes of shares. There are no other classes of shares.
Except for the revision of the above clauses, other clauses in the original Articles of Association remain unchanged. The final changes shall be subject to the approval of the market supervision and management department.
For the revised full text, please refer to the "Articles of Association (Revised in October 2025)" disclosed by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) on October 31, 2025.
Announcement is hereby made.
Board of Directors of Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
October 31, 2025